SCHEMBL6170831

SCHEMBL6170831

CCCc1nc2ccc(N)cc2n1Cc1ccccc1Cl

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.54
ALDH1A1 P00352 2/20 0.54
HPGD P15428 2/20 0.54
KDM4E B2RXH2 1/20 0.54
LMNA P02545 1/20 0.54
NPSR1 Q6W5P4 1/20 0.54
TNF P01375 1/20 0.51
NOD2 Q9HC29 1/20 0.51
NOD1 Q9Y239 1/20 0.51
MEN1 O00255 1/20 0.51
GAA P10253 1/20 0.51
KMT2A Q03164 1/20 0.51
PTGES O14684 1/20 0.49
MAPT P10636 3/20 0.49
TP53 P04637 1/20 0.49
PPARG P37231 2/20 0.48
ALOX5AP P20292 2/20 0.47
TDP1 Q9NUW8 1/20 0.46
TSHR P16473 1/20 0.46
AGTR1 P30556 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6170033 0.85 MEN1 (0.68) SMN1; SMN2KDM4ELMNATNFNOD2
SCHEMBL6170532 0.83 AGTR1 (0.55) SMN1; SMN2ALDH1A1HPGDKDM4ETNF
SCHEMBL6170454 0.83 ALOX5AP (0.55) SMN1; SMN2ALDH1A1HPGDKDM4ELMNA
SCHEMBL6170842 0.83 TNF (0.56) SMN1; SMN2ALDH1A1HPGDKDM4ELMNA
SCHEMBL7671121 0.82 AGTR1 (0.54) SMN1; SMN2ALDH1A1HPGDKDM4ETNF
SCHEMBL6170375 0.82 AGTR1 (0.62) PTGESTP53PPARGTDP1AGTR1
SCHEMBL6171147 0.81 PTGES (0.61) SMN1; SMN2ALDH1A1HPGDKDM4ELMNA
SCHEMBL7675982 0.79 TDP1 (0.57) ALDH1A1HPGDKDM4ETNFNOD2
SCHEMBL6170445 0.79 PTGES (0.65) SMN1; SMN2ALDH1A1HPGDKDM4ETNF
SCHEMBL7673926 0.79 TDP1 (0.62) ALDH1A1HPGDPTGESMAPTTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0882718-B1 BENZIMIDAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO (JP) 2005-08-31 EP disclosed
US-6369092-B1 Method for treating neoplasia by exposure to substituted benzimidazole derivatives CELL PATHWAYS, INC. 2002-04-09 US disclosed
US-6352985-B1 CARDIOVASCULAR DISORDERS OR GASTROINTESTINAL DISORDERS, DIABETES (TYPE II DIABETES), DIABETIC COMPLICATIONS METHOD FOR LOWERING THE BLOOD SUGAR LEVEL OF A PATIENT, FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-03-05 US disclosed
US-6166219-A Benzimidazole derivatives FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-12-26 US disclosed
EP-0882718-A1 BENZIMIDAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-12-09 EP disclosed